Presenting Startups
These six companies are at the cutting edge of medical aesthetics innovation – offering solutions ranging from mitochondrial health to facial and body treatment!
2023 Presenting Companies
Lumisque
Lumisque Skincare presents CO2Lift, a medical-grade brand of super hydrating treatments that delivers Carbon Dioxide to lift, tighten and regenerate the skin. Two transdermal carboxy products featured: CO2Lift Pro, a facial and body treatment mask, and CO2LiftV an at-home vulva/vaginal treatment that helps to lessen the symptoms which are due to inadequate lubrication and lowered estrogen levels, without pain nor downtime. It helps improve natural lubrication and increase sensation during sex. The CO2liftPro and CO2LiftV are used as stand-alone or in combination with procedures that will improve results and reduce downtime.
Presenter: Lana Kerr, CEO
RealizeMD
RealizeMD – an AI-driven medical visual data platform based on real results – Real Results Anonymized. Our proprietary algorithms (Anonymizer, Realizer, Verifier) enable privacy preserving visualization, allowing clinics to use ‘before & after’ visuals of reconstructive and cosmetic procedures while safeguarding patient’s privacy. Our Platform will dramatically increase the candidate participation rates in plastic surgery, dental and medical aesthetics procedures, using AI-based visualization. We’re creating a new language for visual results, by liberating highly regulated visual data. Founded in April 2020 by industry veterans, we’ve released 2 MVPs, RealizeMD SHOW and ANALYZE. We’re looking to raise our Seed/A round to expand development and market penetration.
Presenter: Uri Neeman, CEO
Spiderwort
Spiderwort is a biomaterials company that develops cellulose-based scaffolds for use in regenerative medicine. Its proprietary biomaterial platform consists of the isolation and manufacturing of a repertoire of unique, plant tissue-derived microstructures matching target tissue extracellular matrix structure. A leading application for these biomaterials includes soft tissue augmentation for aesthetic enhancement. Spiderwort aims to disrupt the dermal filler market through the introduction of CelluJuve TM, a long-lasting dermal filler for nasolabial fold remediation and mid-cheek applications (acne scar filling, lipoatrophy). Another core application for these biomaterials is in spinal cord injury (SCI) repair, where Spiderwort’s CelluBridge TM product received a Breakthrough Device Designation from the FDA.
Presenter: Stephen Hanson, PhD, MBA, Director of Business Development
StimuSIL
StimuSIL is the non-invasive alternative to hair transplantation. It uses a patented medical device to deliver photobiostimulation directly to the hair follicle.
The treatment is completely non-invasive, aiming to be competitive with today’s treatments. It is a painless lunchtime procedure, offering aesthetic clinics a new revenue line for existing and new customers.
The untreated hair regrowth market is larger than the treated market, due to the lack of treatments that are both convenient and effective. StimuSIL will be to hair transplants what Botox® has been for facelifts – a non-invasive option that drastically grows the market.
StimuSIL will go to market in 2024, aiming to become the leader in the $300bn hair regrowth market.
Presenter: Pablo Villalba, President
Syntr Health Technologies
Syntr’s premise is to harness the power of the patient’s own fat tissue to treat aging-related conditions. The problem in the medical world today is that we have multiple solutions for each human ailment or condition versus a true platform technology that can target all at once. That is a major bottleneck to advancing the world of medicine and medical aesthetics. Syntr Health Technologies provides the only FDA-cleared automated platform technology to process a patient’s own fat tissue to aid in healing and rejuvenation.
Presenter: Ahmed Zobi, CEO
TissueForm
TissueForm is passionate about improving life for people with volumetric tissue loss. TissueForm advances novel extracellular matrix-based biomaterials to address clinical problems in plastic surgery and regenerative medicine. TissueForm’s first product, NatruDermeTM, is a dermal filler designed to mimic skin. It enters a $3.2B US filler market, where fillers are sold directly to providers. Today, patients who desire procedures for tissue loss using fillers must choose between products that are (1) natural but biologically inert and quickly degrading, or (2) semi-permanent but composed of plastic or synthetic materials. Instead, NatruDermeTM disrupts the tissue repair market by providing a natural and structural biomaterial that closely mimics skin, maximizes durability, minimizes swelling and migration, and is reversible.
Presenter: Jeanne Barthold, Co-founder
Yuva Biosciences, Inc.
YuvaBio is fighting aging, starting with hair and skin, by restoring mitochondrial function. Mitochondrial dysfunction is a key root cause of aging, and YuvaBio is solving this problem with a unique platform that identifies natural compounds that improve mitochondrial health. YuvaBio’s lead compound has already been licensed out and is already in clinical trials, and a pipeline of additional compounds is in place, generated with the help of our advanced AI model. Existing products address only the symptoms of skin and hair aging—it’s time to fight aging at the root cause through mitochondrial science!
Presenter: Greg Schmergel, CEO
Events Search and Views Navigation
April 2023
Octane’s Annual Partner Summit
The Octane Team would like to invite you to our annual Partner Summit. The virtual Summit will be an opportunity share our high-impact results we have had collectively in the community, thank our current partners, and meet with business colleagues. Please be sure to register for the event to receive the log in information via email. We look forward to seeing you there! REGISTER HERE>>
Find out more »Women Leaders of Octane- April 2023 Quarterly Meeting
Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, April 19th from 12:00 – 1:00 pm PST, featuring Thought Leader: Anne Mulcahy In addition to our thought leader, our committee chairs will share progress reports. Our Committees and Committee Chairs: Creating Women-led Businesses & LaunchPad Committee – Marinela Gombosev, SPARK Neuro Funding Committee – Delilah Panio, Toronto Stock Exchange Women on Boards Committee – Joyce Averna, JP Morgan Private Bank Resources & Communications – Nanneke Dinklo Plus, after the WLO Quarterly meeting,…
Find out more »May 2023
Tech Innovation Forum 2023
Tech Innovation Forum 2023 will focus on the acceleration of innovation in technology. The Forum will concentrate on topics such as the next industrial revolution- the role that Southern California is playing in both climate tech and space, and feature topics related to the investment landscape for emerging and growth companies. Learn more. Register here.
Find out more »June 2023
Ophthalmology Tech Forum 2023
Join industry physicians and top ophthalmologists who are defining the future of the field at Octane’s Ophthalmology Technology Forum (OTF). The event is held annually in Orange County, the center for Ophthalmology in the US. We will be hosting Ophthalmology Tech Forum 2023 as a hybrid experience, which will allow our guests to attend in person or online. Learn more Register here
Find out more »July 2023
Women Leaders of Octane – July 2023 Quarterly Meeting
Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, July 19th from 12:00 – 1:00 pm PST, featuring Thought Leader: Cynthia West, Ph.D. In addition to our thought leader, our committee chairs will share progress reports. Our Committees and Committee Chairs: Creating Women-led Businesses & LaunchPad Committee – Marinela Gombosev, SPARK Neuro Funding Committee – Delilah Panio, Toronto Stock Exchange Women on Boards Committee – Joyce Averna, JP Morgan Private Bank Resources & Communications – Nanneke Dinklo Plus, after the WLO Quarterly…
Find out more »September 2023
Cardiovascular Tech Summit 2023
Octane’s Cardiovascular Tech Summit 2023 will synergize innovative solutions in cardiology with physicians, industry strategics, and investors convening together to advance patient care. The Summit will explore the unmet needs in cardiology, highlight current buying trends of strategics and investors, review current funding models of cardiology innovation, present innovation trends, and showcase top emerging cardiology companies to our ecosystem of strategics and investors.
Find out more »High Tech Awards 2023
The much-anticipated High Tech Awards celebrate the top innovators, entrepreneurs, and technology leaders in Orange County. Join us for the 2023 High Tech Awards to celebrate and recognize those individuals and companies who make Orange County a center of technology and medical technology innovation.
Find out more »October 2023
Octane’s Medical Innovation Forum 2023
Octane will host our Medical Innovation Forum 2023 as an in-person experience. Join us in collaborating with industry experts, strategics, physicians, entrepreneurs, and investors who have made significant strides toward an accelerated future in the medical industry. The Forum will highlight the wide-ranging impact of the most recent medical innovations and how the industry will adapt to enhance patient care.
Find out more »